(Q34451373)

2 August 2017

title

Availability of methaqualone from commercial preparations: in vitro and in vivo studies in man. (English)

1 reference

2 August 2017

Williams ME

1

1 reference

2 August 2017

Kendall MJ

2

1 reference

2 August 2017

Mitchard M

3

1 reference

2 August 2017

Davis SS

4

1 reference

2 August 2017

Poxon R

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 1974

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

99-105

1 reference

The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets

2 August 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402450

A comparison of the hypnotic properties of mandrax and its two constituents.

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402450

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402450

Hazard of Therapeutic Nonequivalency of Drug Products*

6 July 2018

1 reference

12 December 2020

Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms

1 reference

12 December 2020

An improved quantitative gas-liquid chromatographic assay for the estimation of methaqualone in biological fluids

1 reference

12 December 2020

Interpretation of Percent Dissolved-Time Plots Derived from In Vitro Testing of Conventional Tablets and Capsules

1 reference

12 December 2020

10.1111/J.1365-2125.1974.TB00217.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference